Purchase Order 75N91018P00504

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc., valued at $21,251.00, on July 22, 2020, for drugs and biologicals. Performance occurs in Pleasanton, California, with an ultimate completion date of August 31, 2020. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $10,718.00 on June 25, 2020, with completion scheduled for July 24, 2020. Performance takes place in Pleasanton, California. The order is firm fixed price with no set-aside designation. The source does not specify the items or services being procured.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $7,849.00 in bio products on December 12, 2017, with an ultimate completion date of January 12, 2018. Work is performed in Pleasanton, California. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on March 15, 2018, with ultimate completion on April 13, 2018. The order covers laboratory supplies under firm fixed price terms. Place of performance is Pleasanton, California.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,554.00 on August 22, 2017, with a completion date of September 21, 2017. The order covers laboratory supplies, with place of performance in Pleasanton, California. Pricing is firm fixed price under a no-set-aside simplified acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $7,081.00 in biological products, effective January 23, 2018, with completion targeted for March 23, 2018. Work is performed in Pleasanton, California. The order procures biological products on a firm-fixed-price basis without set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $5,600 on November 16, 2017, for laboratory supplies. Performance location is Pleasanton, California. The order carries a firm fixed price and ultimate completion date of December 31, 2017.</p>

<p>The National Cancer Institute issued a purchase order to 10X Genomics, Inc. for $22,366.00 in lab supplies, awarded August 15, 2017, with completion by September 13, 2017. Performance occurs at 10X Genomics' facility in Pleasanton, California. The order is firm fixed price with no set-aside category.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc., for drugs and biologicals valued at $21,896.00, effective September 3, 2019, with final completion on September 30, 2019. Place of performance is Pleasanton, California. The order carries no small business set-aside and uses firm fixed price terms.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on May 30, 2018, for lab supplies. Performance occurs at the vendor's facility in Pleasanton, California. The order carries a firm fixed price and is scheduled for completion by June 28, 2018.</p>